Log in to search using one of your social media accounts:

 

Scientists ignored fatal results of TB vaccine, went ahead with trials on human babies
(Natural News) While testing on animals is an undoubtedly detestable practice, it still pales in comparison to testing on human babies. Especially when the product in question has already been shown to kill primates, our close genealogical relatives. But for Big Pharma and other vaccine-pushers, human life is of little consequence — even when talking... (Source: NaturalNews.com)
Source: NaturalNews.com - September 28, 2017 Category: Consumer Health News Source Type: news

How tuberculosis hides in the body
(Norwegian University of Science and Technology) The tuberculosis vaccine only works for children. BCG (bacille Calmette-Guerin) doesn't protect you as an adult. Now we know more about how the bacterium avoids being detected, which is an important step towards better treatment. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 28, 2017 Category: Infectious Diseases Source Type: news

Global Health: Lasting Merit Found in a Tuberculosis Vaccine Invented a Century Ago
BCG vaccine, used in many countries, protects for nearly twice as long as previously thought, scientists find. (Source: NYT Health)
Source: NYT Health - September 1, 2017 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Vaccination and Immunization Tuberculosis International Journal of Epidemiology Source Type: news

TB vaccine BCG effective for twice as long as previously thought – study
Benefits of world ’s only vaccine against tuberculosis were underestimated as new findings reveal it protects against the disease for at least 20 yearsThe BCG, an old vaccine but the only one against tuberculosis, is more effective than was thought, offering protection for at least 20 years, a new study shows.BCG vaccination used to be routine in all secondary schools in the UK for young teenagers, but in recent years it has been given only to those at risk, such as children living in inner-city areas with relatively high TB rates.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 31, 2017 Category: Science Authors: Sarah Boseley Health editor Tags: Medical research Tuberculosis Health Society Science UK news Source Type: news

BCG jab may protect against TB for nearly twice as long as previously thought
(London School of Hygiene& Tropical Medicine) The world's only licensed tuberculosis (TB) vaccine could offer protection against the disease for nearly twice as long as previously thought, according to new research published in the International Journal of Epidemiology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 31, 2017 Category: International Medicine & Public Health Source Type: news

Texas Biomed and UT Health Houston to team on $4.4M tuberculosis vaccine study
Researchers from San Antonio and the Bayou City are working to create an improved vaccine to fight the deadly disease. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 22, 2017 Category: American Health Authors: W. Scott Bailey Source Type: news

Texas Biomed and UT Health Houston to team on $4.4M tuberculosis vaccine study
Researchers from San Antonio and the Bayou City are working to create an improved vaccine to fight the deadly disease. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 21, 2017 Category: Pharmaceuticals Authors: W. Scott Bailey Source Type: news

TX Biomed part of team on 5-year, $4.4 million NIH grant for novel TB vaccine testing
(Texas Biomedical Research Institute) Texas Biomedical Research Institute Associate Scientist Dr. Marie-Claire Gauduin has partnered with Dr. Chinnaswamy Jagannath, professor at McGovern Medical School at UTHealth in Houston to test a modified TB vaccine that, if effective, could prove more powerful and provide longer lasting immunity. Dr. Gauduin and Dr. Jagannath are principal investigators on this five-year, $4.4 million study funded by the National Institutes of Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 21, 2017 Category: International Medicine & Public Health Source Type: news

Tuberculosis Vaccine Candidate MTBVAC Shows Differential Protection Compared With BCG
According to Dr. Nacho Aguiló first author of the study, "there are no specific antigens associated with the efficacy of (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - July 18, 2017 Category: Consumer Health News Source Type: news

Why Big Pharma doesn't want a promising drug to reverse type 1 diabetes
​Dr. Denise Faustman has been working for eight years on using a low-cost tuberculosis vaccine to permanently reverse type I diabetes. But pharmaceutical companies have no interest. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 15, 2017 Category: American Health Authors: Jessica Bartlett Source Type: news

Mass. General study finds potential mechanism for BCG vaccine reversal of type 1 diabetes
(Massachusetts General Hospital) Interim results from a FDA-approved clinical trial testing the generic vaccine bacillus Calmette-Gu é rin to reverse advanced type 1 diabetes demonstrate a potential new mechanism by which the BCG vaccine may restore the proper immune response to the insulin-secreting islet cells of the pancreas. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2017 Category: International Medicine & Public Health Source Type: news

Dartmouth Tuberculosis Vaccine Passes Important Milestone
Investigators at Dartmouth’s Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - May 11, 2017 Category: Hospital Management Authors: Geisel Communications Tags: News DAR-901 DarDar Features Ford Von Reyn global health research TB tuberculosis vaccine Source Type: news

Dartmouth tuberculosis vaccine passes important milestone
(The Geisel School of Medicine at Dartmouth) Investigators at Dartmouth's Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 11, 2017 Category: Infectious Diseases Source Type: news

Tuberculosis vaccine safe for teens with Schistosoma parasite
(PLOS) Of the millions of people at risk for contracting tuberculosis each year, many are already infected with helminths, parasitic worms including Schistosoma flatworms. In some cases, parasite infections can impair the ability of an immunization to work. But adolescents infected with Schistosoma mansoni respond as well as uninfected teens do to a candidate booster tuberculosis vaccine, according to a new study in PLOS Neglected Tropical Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 4, 2017 Category: Infectious Diseases Source Type: news

Health risk of unlicensed drugs in herbal supplements
Experts say those taking supplements should inform their GP Related items fromOnMedica Vitamin D supplements reduce severe asthma attacks Experts recommend everyone take vitamin D supplements New leaflet eases fears over unlicensed BCG vaccine Vitamin D supplements in pregnancy don ’t boost babies’ bone strength No strong evidence that omega 3 supplements alleviate depression (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 5, 2017 Category: UK Health Source Type: news

When Men and Women Differ
By Drs. David Niesel and Norbert Herzog Besides the obvious physical differences, science is beginning to tease out some significant biological differences between men and women that have implications for women's health. A call to action was the measles vaccine that the World Health Organization suddenly had to withdraw after the deaths of infant girls increased but not boys. The cause remains unclear, but it served as a wakeup call to science to pay attention to gender differences when evaluating or testing drugs or vaccines. Fifteen years ago, it was discovered that women infected with HIV, are usually infected by ma...
Source: Science - The Huffington Post - January 25, 2017 Category: Science Source Type: news

Scientists develop potential new TB vaccine
Amy WallaceWASHINGTON, Jan. 13 (UPI) -- Researchers are working on a potential new tuberculosis vaccine that would be the first new TB vaccine in a century to combat drug-resistance. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 13, 2017 Category: Consumer Health News Source Type: news

Cleverly designed tuberculosis vaccine shows promise in mice
A clever new tuberculosis vaccine has shown promise in trials in mice. If it succeeds, it will be the first new TB vaccine in a century. With the rise of multidrug resistant tuberculosis, the difficulty of curing the disease, and the large annual death toll, a successful vaccine could be a huge benefit to public health -- especially in low- and middle income countries. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 13, 2017 Category: Science Source Type: news

Cleverly designed tuberculosis vaccine shows promise in mice
(American Society for Microbiology) A clever new tuberculosis vaccine has shown promise in trials in mice. If it succeeds, it will be the first new TB vaccine in a century. With the rise of multidrug resistant tuberculosis, the difficulty of curing the disease, and the large annual death toll, a successful vaccine could be a huge benefit to public health -- especially in low- and middle income countries. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 13, 2017 Category: Biology Source Type: news

Scientists accelerate immune response to tuberculosis in mice
New research findings provide insight into the immune system pathways that may be key to developing an effective tuberculosis (TB) vaccine. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 22, 2016 Category: Science Source Type: news

Scientists accelerate immune response to tuberculosis
Amy WallaceWASHINGTON, Dec. 22 (UPI) -- Scientists want to improve the current tuberculosis vaccine for adults, which is variable and likely to give false positives. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 22, 2016 Category: Consumer Health News Source Type: news

NIH-supported scientists accelerate immune response to tuberculosis in mice
(NIH/National Institute of Allergy and Infectious Diseases) New research findings provide insight into the immune system pathways that may be key to developing an effective tuberculosis (TB) vaccine. The study, published today in the journal Nature Communications, was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 22, 2016 Category: Infectious Diseases Source Type: news

How the tuberculosis vaccine may protect against other diseases
(Cell Press) The tuberculosis vaccine is well known to help protect against other infectious diseases, as well as cancer, but the exact mechanisms have not been clear. A study publishedin Cell Reports now shows that the broad-spectrum effects of the Bacillus Calmette-Guerin (BCG) vaccine could be mediated by metabolic and epigenetic changes in white blood cells through a process called trained immunity. This discovery could pave the way for strategies that boost the effectiveness of vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 6, 2016 Category: Infectious Diseases Source Type: news

Holding My Breath: Life After Being Diagnosed With TB
In August, I was diagnosed with tuberculosis, an infection that is responsible for more deaths around the world than any other. There was a catch though--it is a latent infection, meaning that it is not spreading nor is it contagious. But if it becomes active, it could be transmitted to my children, my husband and even someone sitting next to me on a plane. Tuberculosis, or TB, is a disease that should be long gone; the bacteria has been found in Egyptian mummies. And yet, TB kills more people today than any other infectious disease in the world: 1.8 million people in 2015, according to an announcement last week by the Wo...
Source: Healthy Living - The Huffington Post - November 12, 2016 Category: Consumer Health News Source Type: news

Tuberculosis bacteria find their ecological niche
(German Center for Infection Research) An international team of researchers have isolated and analyzed genetically tuberculosis bacteria from several thousand patients from over a hundred countries. This analysis demonstrates that the tuberculosis bacteria vary in their ecological niche. Whereas the so-called generalists occur all around the world, the specialists are only found in certain geographical regions. This finding, published in the renowned journal Nature Genetics, could further complicate the development of novel tuberculosis vaccines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 3, 2016 Category: Global & Universal Source Type: news

Guidance for nurses on using unlicensed BCG
Nurses and other healthcare professionals are to receive new guidance on the unlicensed BCG jab that is being used in response to the current global shortage of the tuberculosis vaccine. (Source: Nursing Times)
Source: Nursing Times - August 23, 2016 Category: Nursing Source Type: news

Uganda: BCG Vaccination Could Improve Survival of HIV Exposed Babies
[Monitor] In 2015, it was estimated that nearly 10 out of every 100 Ugandan children born alive do not live beyond their fifth birthday and in total, 39,000 new-borns die every year. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 15, 2016 Category: African Health Source Type: news

Toward an effective TB vaccine: Analysis of the immune response to a promising candidate
BCG, the only currently approved TB vaccine, is only partially effective. Given the complicated TB treatment, the rise of adult TB cases in conjunction with the HIV epidemic, and increasing multidrug-resistant TB strains, a new and better vaccine is a global health priority. A new study dissects the immune response in mice to an experimental vaccine and shows why it is highly effective. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 28, 2016 Category: Science Source Type: news

Toward an effective TB vaccine: Analysis of the immune response to a promising candidate
( PLOS ) BCG, the only currently approved TB vaccine, is only partially effective. Given the complicated TB treatment, the rise of adult TB cases in conjunction with the HIV epidemic, and increasing multidrug-resistant TB strains, a new and better vaccine is a global health priority. A study published on July 28 in PLOS Pathogens dissects the immune response in mice to an experimental vaccine and shows why it is highly effective. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 28, 2016 Category: Infectious Diseases Source Type: news

New leaflet eases fears over unlicensed BCG vaccine
Global BCG vaccine shortage means the NHS is importing vaccine from CanadaRelated items from OnMedicaTuberculosis: a rising health concern Tackling tuberculosisNew pledge to end TB by 2035Improve uptake of MMR jab to meet WHO targetFlu nasal spray fine for children with egg allergy (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 27, 2016 Category: UK Health Source Type: news

Vaccine update: June 2016, special edition
This special edition of vaccine update features information on the central supply of the BCG vaccine, and ordering through ImmForm and advice on prioritisation of local BCG vaccine stock. (Source: NHS Networks)
Source: NHS Networks - June 23, 2016 Category: UK Health Source Type: news

Tanzania: Govt Seeks Solution to Shortage of Vaccine
[Daily News] Zanzibar -The government has been doing all it can to ensure that the shortage of the BCG vaccine for newborns is arrested, the House of Representative was told here yesterday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 23, 2016 Category: African Health Source Type: news

Biomarker discovery offers hope for new TB vaccine
Researchers have identified new biomarkers for Tuberculosis (TB) which have shown for the first time why immunity from the widely used Bacillus Calmette-Guérin (BCG) vaccine is so variable. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 12, 2016 Category: Science Source Type: news

Biomarker discovery offers hope for new TB vaccine
(University of Oxford) Researchers have identified new biomarkers for Tuberculosis (TB) which have shown for the first time why immunity from the widely used Bacillus Calmette-Guérin (BCG) vaccine is so variable. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 12, 2016 Category: Infectious Diseases Source Type: news

This Disease Can Still Get You Quarantined For Months -- And It's On The Rise
In August 2014, Kate O’Brien, a 34-year-old media producer from Brooklyn, found out she was expecting her second child. She was ecstatic. But this pregnancy didn't proceed like the first. For the next few months, O'Brien had a cold she couldn't shake. She woke up in the middle of the night drenched in sweat. She wanted to blame it on her pregnancy, yet she kept losing weight. She could barely eat. She coughed up balls of bloody mucus. Her throat burned. None of her doctors could figure out what was wrong. A physician sent her to Mount Sinai West Hospital in Manhattan in January 2015, when, at five months pregnant, sh...
Source: Science - The Huffington Post - March 24, 2016 Category: Science Source Type: news

Kenya: Health CS Says Unicef to Blame for Vaccine Delay
[Nation] Hospitals will wait until next week for the second batch of BCG vaccine, used against tuberculosis, the government has said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 22, 2016 Category: African Health Source Type: news

Kenya: 4.7 Million New TB Vaccine Doses Set to Arrive in March
[Nation] A new batch of about 4.7 million doses of BCG vaccine that protects children from contracting tuberculosis (TB) is expected to arrive in Kenya next month. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - February 26, 2016 Category: Infectious Diseases Source Type: news

Persistent pollutants linked to poor vaccine response
New research indicates that exposure to pollutants such as DDT and PCBs may dampen infants’ immune response to the tuberculosis vaccine. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - January 12, 2016 Category: Environmental Health Source Type: news

Toxic Chemicals May Weaken Infants' Response to TB Vaccine
Title: Toxic Chemicals May Weaken Infants' Response to TB VaccineCategory: Health NewsCreated: 12/18/2015 12:00:00 AMLast Editorial Review: 12/21/2015 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - December 21, 2015 Category: Pediatrics Source Type: news

Toxic Chemicals May Weaken Infants' Response to TB Vaccine
PCBs, DDT found in babies' blood samples appear to dampen immunity, study says Source: HealthDay Related MedlinePlus Pages: Environmental Health, Immunization, Infant and Newborn Care (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 18, 2015 Category: Consumer Health News Source Type: news

Exposure to chemicals lowers babies' TB vaccine response
Stephen FellerROCHESTER, N.Y., Dec. 9 (UPI) -- Exposure of mothers and babies to certain chemicals was shown to lower the immune response to the tuberculosis vaccine in infants in Slovakia in a recent study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 9, 2015 Category: Consumer Health News Source Type: news

Is chemical exposure in mothers, babies, linked to poor vaccine response?
Early life exposures to toxic chemicals such as PCBs and DDT dampen an infant's response to the tuberculosis vaccine, according to a new study. PCBs were used in manufacturing and in consumer products in the United States until their ban in 1979. Despite this, nearly all people have detectable concentrations in their blood, even those who live in unindustrialized areas around the globe. DDT, although banned in the U.S., is still used in some countries to control malaria spread by mosquitos. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 9, 2015 Category: Science Source Type: news

Quest for tuberculosis vaccine begins as scientists aim to beat disease by 2035 | Andrew Green
In South Africa and beyond, thousands of TB cases emerge each year despite the BCG vaccine. An ambitious plan seeks to end what has become a global epidemicWhen her son Luluto was born 16 years ago, Yoliswa Qaku was eager to have him vaccinated against tuberculosis. Once he received the injection, she thought, he would be safe from the disease for the rest of his life. She learned earlier this year that this was never the case. Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 7, 2015 Category: Science Authors: Andrew Green in Cape Town Tags: Global development Tuberculosis Health Society South Africa World news Medical research Source Type: news

Japan’s GHIT Fund Supports Dartmouth Researchers’ Second Tuberculosis Vaccine Trial
A collaborative of Dartmouth’s Geisel School of Medicine, Muhimbili University of Health and Allied Sciences in Tanzania, and Tokyo Medical and Dental University received $1.4 million from Japan’s Global Health Innovative Technology Fund to conduct a joint randomized clinical trial in Tanzania aimed at reducing the transmission of tuberculosis. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - November 5, 2015 Category: Hospital Management Authors: Susan Green Tags: News DarDar Features Ford Von Reyn TB tuberculosis vaccine Source Type: news

Africa: South Africa Plugs TB Vaccine Gap
[News24Wire] Cipla Medpro has entered into an agreement with the Serum Institute of India (SII) to provide South Africans with affordable and accessible vaccines, including BCG which is the only vaccine against tuberculosis (TB). BCG was recently out of stock. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - November 2, 2015 Category: Infectious Diseases Source Type: news

Tuberculosis mortality nearly halved since 1990
The fight against tuberculosis is paying off, with this year’s death rate nearly half of what it was in 1990. Nevertheless, 1.5 million people died from TB in 2014. Most of these deaths could have been prevented, according to WHO’s Global tuberculosis report 2015, which was released today in Washington. To reduce TB’s overall burden, detection and treatment gaps need to be closed, funding shortfalls filled and new diagnostics, drugs and vaccines developed, according to the report. (Source: WHO news)
Source: WHO news - October 28, 2015 Category: Global & Universal Tags: diagnostics [subject], diagnostic procedures, diagnostics, diagnostic imaging, tuberculosis [subject], tb, tuberculosis [subject], tb, vaccines [subject], vaccine, vaccine safety, vaccine quality, vaccines [subject], vaccine, vaccine safety, vaccine quali Source Type: news

Tulane researchers working on new tuberculosis vaccine
(Tulane University) Researchers at the Tulane National Primate Research Center are leading efforts to find a new vaccine for tuberculosis, one of the world's deadliest diseases. A team of researchers led by the TNPRC used a modified strain of TB to show that monkeys could generate better protective immunity than when vaccinated with BCG, a common TB vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 13, 2015 Category: Infectious Diseases Source Type: news

IDRI, Wellcome Trust team for tuberculosis vaccine trial in South Africa
(Infectious Disease Research Institute) Today, the Infectious Disease Research Institute (IDRI) and Wellcome Trust announce the start of a Phase 2a trial in South Africa of IDRI's tuberculosis vaccine candidate, which has been shown to both prevent and treat TB in preclinical studies in animal models. The Wellcome Trust awarded IDRI a $5.8 million/£3.8 million grant to clinically assess the ability of IDRI's vaccine candidate to reduce TB recurrence after treatment. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 17, 2015 Category: Infectious Diseases Source Type: news

Zimbabwe: BCG Vaccine in Short Supply
[The Herald] Thousands of babies born in recent months could have been exposed to tuberculosis bacteria following a global shortage of the Bacillus Calmette-Guérin (BCG) vaccine. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 7, 2015 Category: African Health Source Type: news

South Africa: Babies At Risk of Contracting TB Due to BCG Vaccine Shortage
[DA] Today I will write to Health Minister Dr Aaron Motsoaledi to call on him to explain to the South African public why we have run out of anti-tuberculosis vaccinations and to reassure us that the problem will not be repeated. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - September 7, 2015 Category: Infectious Diseases Source Type: news